1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Biopharmaceutical

Biopharmaceutical Sector: Get Market Research and Figures

  • Currently 3/5 Stars.
  • 1
  • 2
  • 3
  • 4
  • 5
30 votes

Global Biopharmaceutical Industry

The global biopharmaceutical industry (a part of the biotechnology market) is currently worth over $145 billion, according to research conducted by BioPlan Associates. The industry should exceed $167 billion in 2015, says IMARC. 

Biopharmaceuticals are used in the prevention and treatment of disease, and there are over 300 approved biopharmaceuticals on the market, with many in clinical development yet to come. The market has benefited from the need for pharmaceutical manufacturers to boost output, but it has a high risk factor, with only three out of 10 drugs that pass to the clinical phase receiving market clearance.

Cost containment and biosimilar entry in developed markets continue to see slow growth, but the market should expand thanks to biopharmaceutical capacity to outperform traditional small molecule drugs. Over the coming five-year period, factors such as development of emerging markets and a rich late-stage pipeline are expected to fuel growth.

Key Biopharmaceutical Market Segments

The world biosimilar market is expected to record yearly growth in excess of 50% between 2010 and 2015, reports RNCOS. Market growth is being driven by factors such as costly drugs, high pharmaceutical expenditure and a global aging population. Market expansion will be further fuelled by expiring patents and the increasing cost of drugs. Sandoz is the leading company operating in the global biosimilars market, recording the highest sales. Teva and Hospira are developing a biosimilar product range.

The global enzyme market is expected to exceed $7.5 billion in 2015, reports Freedonia, and it should surpass yearly growth of 5%. The fastest rate of growth will be recorded in smaller markets such as the Africa/Middle East region, and Central and South America. Asia-Pacific is expected to record strong growth, while the EU and North America are forecast to record below-average growth.

The global protein therapeutics market is forecast to see yearly growth of 13% between 2012 and 2014, reports RNCOS. Increased investment and the introduction of new protein therapeutics will fuel market  expansion. Protein therapeutics have been recording a high rate of growth in recent years, vital to the treatment of many diseases. Protein therapeutics are particularly efficient due to their targeted approach, which allows the treatment of disease with little or no negative impact on healthy organs. Protein therapies are necessary in a healthcare landscape, witnessing rapidly rising rates of chronic illnesses like cardiovascular diseases, diabetes and cancer.

The cancer monoclonal antibodies market is expected to grow at a yearly rate in excess of 5% between 2012 and 2015, according to RNCOS. Cancer monoclonal antibodies are used to treat tumors with a high degree of specification. The market is driven by increasing prevalence of cancer and the need for more innovation research. The industry is witnessing rising consolidation.

Read more »

You might be interested in these related markets:

Customer Support

Talk to Sam

+1 718 303 2384

7700 Reports
Biosimilar Approvals, Biologics Approval, Biologics Production, Biologics Sales
23 Statistics
Pharmaceutical Exports, Pharmaceutical Imports, Biologics Production, Biologics Sales
5200 Reports
Biosimilar Approvals, Biologics Approval, Biologics Production, Biologics Patents Registrations
4100 Reports
Biosimilar Approvals, Biologics Approval, Biologics Sales, Biologics Production
6 Statistics
Pharmaceutical Imports, Pharmaceutical Exports
540 Reports
Biosimilar Penetration Rate, Biosimilar Approvals, Biologics Production, Biologics Penetration Rate
620 Reports
Biologics Production, Biologics Sales, Biologics Approval, Biosimilar Approvals
450 Reports
Biologics Production, Biologics Sales, Biosimilar Approvals, Biosimilar Penetration Rate
16 Statistics
Pharmaceutical Imports, Pharmaceutical Exports
570 Reports
Biosimilar Approvals, Biologics Approval, Biologics Production, Biosimilar Penetration Rate
44 Statistics
Pharmaceutical Imports, Pharmaceutical Exports
680 Reports
Biosimilar Approvals, Biologics Sales, Biosimilar Penetration Rate, Biologics Production
36 Statistics
Pharmaceutical Exports, Pharmaceutical Imports
460 Reports
Biologics Production, Biosimilar Approvals, Biologics Sales, Biosimilar Sales
460 Reports
Biologics Production, Biosimilar Approvals, Biosimilar Sales, Biologics Sales
20 Statistics
Pharmaceutical Imports, Pharmaceutical Exports
Search in Biopharmaceutical Industry (About 1200 reports)
Parent industry: Pharmaceutical
Related industries: Drug Delivery, Drug Development, Generic Drug, OTC, Pharmacy, Prescription Drug, Therapy

About 5600 reports

Purchase Reports From Reputable Market Research Publishers

Immunoglobulins Global Market Report 2021: COVID-19 Implications And Growth

  • $ 5000
  • September 2021
  • 175 pages

Major players in the immunoglobulins market are Baxter International Inc., CSL Behring LLC, Grifols S.A., Octapharma, China Biologic Products Inc., Kedrion S.p.A., LFB group, Biotest AG, Sanquin, ADMA ...

  • World
  • United States
  • Biopharmaceutical
  • Neurological Disorder
  • Industry analysis

Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on